✦ LIBER ✦

S 4.6 - Immunotherapy of Cancer

Publisher: John Wiley and Sons
Year: 2009
Tongue: English
Weight: 99 KB
Volume: 39
Category: Article
ISSN: 0014-2980
DOI: 10.1002/eji.200990234

No coin nor oath required. For personal study only.

✦ Synopsis

Abstract

No Abtract

📜 SIMILAR VOLUMES

Immunotherapy of bladder cancer

✍ Unyime O. Nseyo; Donald L. Lamm 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 English ⚖ 48 KB 👁 2 views

Intravesical therapy has been used in the management of superficial transitional cell carcinoma (TCC) of the urinary bladder (i.e., Ta, Tl, and carcinoma in situ) with specific objectives which include treating existing/residual tumor, preventing recurrence of tumor, preventing disease progression,

S 4.3 - Optimizing Immunotherapies

📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 82 KB

Immunotherapy of metastatic kidney cance

Immunotherapy of metastatic kidney cancer

✍ Giancarlo Pizza; Caterina De Vinci; Giuseppe Lo Conte; Paolo Maver; Ennio Dragon 📂 Article 📅 2001 🏛 John Wiley and Sons 🌐 French ⚖ 337 KB

122 MRCC patients were treated by monthly intralymphatic injections (containing a mean of 573 IL-2 U and 26 ؋ 10 6 LAK cells) and i.m. administration of IFN and TF; 71 patients also received a 3-day cycle of monthly IL-2 inhalations with a mean of 998 daily U. MRCC cases not treated by immunotherapy

Immunotherapy of cancer: A perspective v

Immunotherapy of cancer: A perspective view

✍ R. A. Reisfeld 📂 Article 📅 1988 🏛 John Wiley and Sons 🌐 English ⚖ 692 KB

The current intense interest in cancer immunotherapy is largely based on the fact that progress in the clinical treatment of solid tumors has been less spectacular than anticipated, whereas efforts in basic and preclinical cancer research made some rather remarkable strides during the last two decad

Immunotherapy of guinea pig cancer with

Immunotherapy of guinea pig cancer with bcg

✍ Berton Zbar; Herbert J. Rapp 📂 Article 📅 1974 🏛 John Wiley and Sons 🌐 English ⚖ 976 KB

Progress in active specific immunotherap

Progress in active specific immunotherapy of prostate cancer

✍ Benjamin A. Tjoa; Gerald P. Murphy 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 English ⚖ 124 KB 👁 2 views

Treatments available for metastatic prostate cancer have failed to demonstrate significant curative potential. Current efforts are now directed towards developments of novel strategies for the treatment of metastatic prostate cancer. Cancer immunotherapeutic strategies utilize patient immune system